Tag: Pfizer

Systemic Lupus Erythematosus Market Share, Opportunities and Forecast by 2025 | Key Industry Players Roche, Pfizer, Novartis

The global systemic lupus erythematosus market size is expected to reach USD 3.08 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.0% during the forecast period. Introduction of new biological therapies, which will add to treatment alternatives and medication costs, in the development pipeline is estimated to fuel... Continue Reading →

0

Hyperlipidemia Drugs Market Growth Analysis, Opportunities and Forecast by 2022 | Key Industry Participants Pfizer, Daiichi Sankyo

The global hyperlipidemia drugs market size is expected reach USD 22.6 billion by 2022, according to a new report by Grand View Research, Inc., expanding at a CAGR of 2.3% during the forecast period. Several factors, such as increase in target population and growth in awareness about risk of cardiovascular diseases (CVD) due to persistent hypercholesterolemia, are... Continue Reading →

0

Systemic Lupus Erythematosus Market Size Worth $212.0 Million by 2026 | Key Industry participants Glaxosmithkline, Roche, Pfizer, Novartis

San Francisco, 19 September 2018;  The global Systemic Lupus Erythematosus Market size is expected to reach USD 3.08 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.0% during the forecast period. Introduction of new biological therapies, which will add to treatment alternatives and medication costs, in the development... Continue Reading →

0

Create a website or blog at WordPress.com

Up ↑

Design a site like this with WordPress.com
Get started